Ultrasound Workspace (UWS 6.0) vs Zio AT ECG Monitoring System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by iRhythm Technologies, Inc.

AI Verdict

Tool A is an AI-powered system focused on streamlining echocardiography workflows, offering advanced viewing, analysis, and reporting for cardiovascular images. In contrast, Tool B is a wearable mobile cardiac telemetry system that provides continuous, AI-powered ECG monitoring for long-term arrhythmia detection. While both leverage AI in cardiology, they address distinct diagnostic needs: image analysis for structural/functional assessment versus physiological monitoring for electrical activity.

Choose Ultrasound Workspace (UWS 6.0) if…

Choose Philips Ultrasound Workspace (UWS 6.0) if your institution requires a comprehensive, scalable solution for in-depth echocardiography analysis and reporting, especially across a multi-vendor imaging environment. This tool is ideal for standardizing cardiac imaging workflows, enhancing diagnostic confidence with AI-powered measurements, and integrating seamlessly with existing PACS and EMR systems for a holistic view of patient data.

View Ultrasound Workspace (UWS 6.0) →

Choose Zio AT ECG Monitoring System if…

Choose Zio AT ECG Monitoring System if you need a long-term, continuous, and remote solution for detecting and diagnosing cardiac arrhythmias in an ambulatory setting. This wearable system is best suited for identifying intermittent or asymptomatic cardiac events over an extended period, providing real-time data transmission and AI-powered analysis for comprehensive clinician reports.

View Zio AT ECG Monitoring System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Ultrasound Workspace (UWS 6.0) Zio AT ECG Monitoring System
Pricing Unknown Contact for pricing
Deployment On-premise (single-seat workstation, multi-seat server) Cloud-based (data analytics and clinician portal)
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Zio AT ECG Monitoring System

Tool B, the Zio AT ECG Monitoring System, offers a highly patient-friendly experience with its comfortable wearable patch and dedicated mobile apps for both patients and clinicians. Patient testimonials frequently highlight its ease of use and minimal impact on daily life compared to traditional monitoring methods.

Clinical Value

Zio AT ECG Monitoring System

The Zio AT ECG Monitoring System demonstrates superior clinical value through extensive real-world evidence from large studies (CAMELOT, AVALON), showing a higher diagnostic yield for arrhythmias and lower retest rates compared to other ambulatory cardiac monitoring services. Its FDA-cleared deep-learned AI algorithm is clinically proven to perform at the level of cardiologists.

Pricing & Value

Tie

Both tools require direct contact for pricing, limiting transparency. While Tool A offers flexible licensing models, Tool B has established reimbursement pathways with major insurers and Medicare, and provides patient financial assistance programs. However, an ongoing DOJ investigation into Zio AT's reimbursement claims introduces a degree of uncertainty.

Enterprise Readiness

Ultrasound Workspace (UWS 6.0)

Philips Ultrasound Workspace (UWS 6.0) is designed for comprehensive enterprise integration, offering a scalable platform with flexible deployment options including on-premise and server-client networks, alongside web-based access. It explicitly supports integration with existing PACS and EMR systems using DICOM and HL7 standards, making it highly adaptable for diverse hospital IT infrastructures.

Innovation

Zio AT ECG Monitoring System

The Zio AT ECG Monitoring System represents a more disruptive innovation with its wearable, long-term (up to 14 days), continuous ECG monitoring and real-time data transmission. Its FDA-cleared deep-learned AI algorithm for arrhythmia detection significantly advances cardiac diagnostics beyond traditional methods, improving both patient experience and diagnostic yield.

Support & Docs

Tie

Both companies offer robust support structures. Philips provides a comprehensive customer service portal, phone support, and educational resources for healthcare professionals, including specific contacts for UWS 6.0. iRhythm offers 24/7 patient and clinician support via phone and email, along with extensive FAQs and patient education materials.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Ultrasound Workspace (UWS 6.0) Zio AT ECG Monitoring System
Product Name Ultrasound Workspace (UWS 6.0) Zio AT ECG Monitoring System
Company Philips Ultrasound iRhythm Technologies, Inc.
Primary Function Holistic, scalable, AI-powered cardiovascular viewing, analysis, and reporting system designed to streamline echocardiography workflows. FDA-cleared, wearable mobile cardiac telemetry (MCT) service offering continuous, AI-powered ECG monitoring for long-term arrhythmia detection and comprehensive reporting.
AI-Powered Capabilities AI-powered automated measurements (e.g., Auto Measure, AutoStrain LV, 3D Auto RV, 3D Auto MV, 3D Auto TV, 3D Auto CFQ). FDA-cleared deep-learned AI algorithm (ZEUS System) for arrhythmia detection.
Data Analysis/Monitoring Scope Comprehensive cardiovascular software solutions (review, image analysis, reporting, image management) for echocardiography. Continuous, uninterrupted ECG recording for up to 14 days; detection of symptomatic and asymptomatic cardiac events.
Wearable Component Not specified Wearable Zio AT patch for continuous ECG recording.
Vendor Neutrality Vendor-neutral and multi-vendor data analysis for standardization. Not specified

Videos

Demos, reviews, and walkthroughs featuring Ultrasound Workspace (UWS 6.0) and Zio AT ECG Monitoring System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Philips Ultrasound Workspace (UWS 6.0) is designed to streamline echocardiography workflows, enhance diagnostic confidence, and improve reproducibility through cardiovascular viewing, analysis, and reporting. The Zio AT ECG Monitoring System offers continuous, AI-powered ECG monitoring for long-term arrhythmia detection and comprehensive reporting.
UWS 6.0 features AI-powered automated measurements for echocardiography, such as Auto Measure, AutoStrain LV, and 3D Auto RV. The Zio AT ECG Monitoring System utilizes an FDA-cleared deep-learned AI algorithm (ZEUS System) specifically for arrhythmia detection from continuous ECG recordings.
Philips Ultrasound Workspace (UWS 6.0) offers integration with existing PACS and EMR systems. The Zio AT ECG Monitoring System provides a ZioSuiteu00ae clinician portal and mobile app for patient management and report interpretation, and a MyZiou00ae patient mobile app for symptom logging and education.
Philips Ultrasound Workspace (UWS 6.0) explicitly provides vendor-neutral and multi-vendor data analysis for standardization. The Zio AT ECG Monitoring System is a specific product from iRhythm Technologies and does not mention vendor-neutral analysis capabilities.
Ultrasound Workspace (UWS 6.0) focuses on the review, image analysis, and reporting of cardiovascular imaging data from echocardiography. The Zio AT ECG Monitoring System collects continuous, uninterrupted ECG recording data for up to 14 days via a wearable Zio AT patch.
Philips Ultrasound Workspace (UWS 6.0) supports Cardiology, Critical Care, and Radiology specialties. The Zio AT ECG Monitoring System is primarily focused on Cardiology.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.